UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$234M |
| 2 |
Home Depot
HD
|
+$214M |
| 3 |
Intercontinental Exchange
ICE
|
+$206M |
| 4 |
TJX Companies
TJX
|
+$129M |
| 5 |
BorgWarner
BWA
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$227M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$212M |
| 3 |
Mohawk Industries
MHK
|
+$137M |
| 4 |
Liberty Global Class A
LBTYA
|
+$114M |
| 5 |
Freeport-McMoran
FCX
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.05% |
| 2 | Technology | 13.96% |
| 3 | Financials | 13.95% |
| 4 | Industrials | 9.13% |
| 5 | Energy | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Thomson Reuters
TRI
$43B
| $1.53M | ﹤0.01% |
36,346
| – | – |
|
1377
Fulton Financial
FULT
$4.73B
| $1.53M | ﹤0.01% |
123,691
+1,500
| +1% | +$18.3K |
|
1378
Armstrong World Industries
AWI
$7.86B
| $1.52M | ﹤0.01% |
26,482
+3,200
| +14% | +$173K |
|
|
AXLL
1379
DELISTED
AXIALL CORP COM STK (DE)
AXLL
| $1.52M | ﹤0.01% |
32,135
+400
| +1% | +$18.5K |
|
1380
ScottsMiracle-Gro
SMG
$3.85B
| $1.51M | ﹤0.01% |
26,611
| – | – |
|
|
ISBC
1381
DELISTED
Investors Bancorp, Inc.
ISBC
| $1.51M | ﹤0.01% |
136,767
+96,755
| +242% | +$1.03M |
|
1382
B2Gold
BTG
$5.46B
| $1.51M | ﹤0.01% |
515,747
+16,200
| +3% | +$44K |
|
|
AEC
1383
DELISTED
ASSOCIATED ESTATES REALTY CORP
AEC
| $1.5M | ﹤0.01% |
83,531
+1,200
| +1% | +$20.8K |
|
1384
Federated Hermes
FHI
$4.78B
| $1.5M | ﹤0.01% |
48,525
+500
| +1% | +$14.5K |
|
1385
Archrock
AROC
$5.95B
| $1.5M | ﹤0.01% |
33,298
| – | – |
|
|
CHMT
1386
DELISTED
Chemtura Corporation
CHMT
| $1.5M | ﹤0.01% |
57,263
+2,200
| +4% | +$54.2K |
|
1387
Empire State Realty Trust
ESRT
$843M
| $1.49M | ﹤0.01% |
90,138
+21,900
| +32% | +$352K |
|
|
ENH
1388
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $1.49M | ﹤0.01% |
28,773
| – | – |
|
1389
PennantPark Floating Rate Capital
PFLT
$704M
| $1.48M | ﹤0.01% |
103,768
-380
| -0.4% | -$5.26K |
|
|
RGC
1390
DELISTED
Regal Entertainment Group
RGC
| $1.48M | ﹤0.01% |
70,166
| – | – |
|
|
FSP
1391
Franklin Street Properties
FSP
$48M
| $1.48M | ﹤0.01% |
117,497
+3,200
| +3% | +$39.7K |
|
|
HDS
1392
DELISTED
HD Supply Holdings, Inc.
HDS
| $1.48M | ﹤0.01% |
52,100
+16,600
| +47% | +$442K |
|
|
ELP
1393
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $1.47M | ﹤0.01% |
240,393
-29,500
| -11% | -$174K |
|
1394
Belden
BDC
$5.01B
| $1.47M | ﹤0.01% |
18,799
| – | – |
|
1395
Mercado Libre
MELI
$97.5B
| $1.47M | ﹤0.01% |
15,399
+400
| +3% | +$35K |
|
|
CHS
1396
DELISTED
Chicos FAS, Inc.
CHS
| $1.47M | ﹤0.01% |
86,444
-399,650
| -82% | -$6.4M |
|
|
MIC
1397
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $1.47M | ﹤0.01% |
23,499
+600
| +3% | +$35.4K |
|
1398
Thor Industries
THO
$4.14B
| $1.46M | ﹤0.01% |
25,706
+1,000
| +4% | +$59.9K |
|
1399
Cognex
CGNX
$11.8B
| $1.46M | ﹤0.01% |
75,996
| – | – |
|
|
DATA
1400
DELISTED
Tableau Software, Inc.
DATA
| $1.46M | ﹤0.01% |
20,400
-35,800
| -64% | -$2.24M |
|
Similar funds
UBS AM's Q2 2014 Portfolio in Review
As of Q2 2014, UBS AM held 2,651 positions worth $99B, up 5.7% from $93.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2014 filing shows 81 new, 1,135 increased, 556 reduced and 97 closed positions. Its largest new stake was Sabre: 3,529,400 shares worth $70.8M. The largest sale was Allergan Inc, an estimated $227M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q2 2014 buy was Sabre: 3,529,400 shares worth $70.8M.
- UBS AM added most to Thermo Fisher Scientific in Q2 2014, an estimated $234M increase.
- UBS AM's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $227M.
- UBS AM fully exited Freeport-McMoran in Q2 2014, selling an estimated $112M.
- UBS AM's ten largest holdings make up 14% of its $99B portfolio in Q2 2014.
- UBS AM opened 81 new positions and closed 97 in Q2 2014.
- UBS AM's portfolio value rose 5.7% quarter-over-quarter to $99B.
Based on UBS AM's 13F filing for Q2 2014, filed 13 Aug 2014.